Reframing the IND: From Tactical Requirement to Strategic Opportunity ByMichael F Murphy, MD, PhDOctober 15th 2025How a strategic approach to the pre-investigational and investigational new drug application process can be used as a business and clinical catalyst.
Evolution of Value for Oncology TherapiesByMichael F Murphy, MD, PhD,Nicole Sweeney,Thomas F. GossSeptember 8th 2015Background: